Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies

Rheumatology (Oxford). 2000 Jan;39(1):1-2. doi: 10.1093/rheumatology/39.1.1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Rheumatic Diseases / drug therapy*
  • Rheumatology / methods*
  • Sulfasalazine / therapeutic use
  • Survival Analysis

Substances

  • Antirheumatic Agents
  • Sulfasalazine